Skip to main content

Table 2 Follow-up and the fate of managed patients

From: Hepatic resection versus microwave ablation for the treatment of early hepatocellular carcinoma: a comparative analysis of treatment outcomes and survival predictors

  Hepatectomy (N = 31) Percutaneous microwave (N = 37) Intraoperative microwave (N = 4) P value
Response to treatment (according to mRECIST) (count/%)
 • Complete response 29 (93.6%) 30 (81.1%) 3 (75%) 0.331
 • Partial response 2 (6.4%) 5 (13.5%) 1 (25%)
 • Stationary disease 0 (0%) 2 (5.4%) 0 (0%)
 • Progressive disease 0 (0%) 0 (0%) 0 (0%)
Recurrence and progression (count/%)
 • Recurrence 3 (9.7%) 3 (8.1%) 0 (0%) 0.733
 • Portal vein thrombosis Yes 0 (0%) 1 (2.4%) 1
No 31 (100%) 40 (97.6%)
 • Lymph node deposits Yes 2 (6.5%) 0 (0%) 0.182
No 29 (93.5%) 41 (100%)
Clinical decompensation (mean/SD) 5 (16.1%) 5 (13.5%) 1 (25%) 0.656
New ascites Yes 1 (3.2%) 0 (0%) 0.431
No 30 (96.8%) 41 (100%)
Mortality 7 (22.6%) 13 (35.1%) 1 (25%) 0.545